Current location:Home News Information 公司新闻
US FDA OTC Cleared - Citest DOA Rapid Tests
Release Time:2023-12-12

In recent times, the issue of drug abuse has become increasingly rampant. Citest has been dedicated to combating this problem and making a positive impact.


We are proud to announce that several of our DOA rapid tests got US FDA OTC successfully registered. This recognition from the US FDA signifies the quality and reliability of our products. Our DOA product line covers a wide range of drug detections, including AMP, BAR, COC, and more. We offer a diverse selection of test formats to meet the specific needs of our customers. Our tests are of high quality, trustworthy, resistant to tampering, and highly accurate. We aim to contribute to the efforts of drug enforcement agencies, hospitals, and courts in various regions by providing them with effective tools to combat drug abuse.


Citest remains committed to innovation and continuous research and development to meet the evolving needs of our customers and address the societal challenges associated with drug abuse.


CITEST’s Invitation - Medlab Middle East 2024 CITEST’s Invitation - Medlab Middle East 2024